NORTHERN OIL & GAS, INC. (NOG): what the price assumes

boothcheck covers NORTHERN OIL & GAS, INC. (NOG) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-06-27.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/NOG

Headline

FieldValue
TickerNOG
CompanyNORTHERN OIL & GAS, INC.
Current price$19.76/sh
CompositionOil Sales 78% / Natural Gas and NGL Sales 22%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)9.7%
Operating margin (mid-cycle)29.0%
Margin compression (value-band)-19.3pp
Trailing margin (depressed year)-34.0%
Multiple paid8x mid-cycle operating income

The operating-margin figure is value-band context at year 5: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 8.1% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-0.31σ
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple value, while growth-DCF lands below the price. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.24x2expensive
Earnings0.32x2justifies
Relative0.93x2justifies
Growth3.29x3expensive

Families that justify the price: Asset, Earnings, Relative Families that call it expensive: Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 4.9%); the inversion above states its own rate.

Per-Model Detail (n=9)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$148.750.13xyesFCF base $1.4B, growth -10% (input: historical growth), terminal g 0.5%, WACC 4.9%, 5yr projection
DCF Exit MultipleGrowth$0.00noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelative$21.310.93xyesP/S fallback (negative EPS): Sector P/S 1.2x × TTM revenue — excluded from consensus
Simple DDMGrowth$2.487.97xyesDPS $1.68, g=-34.9% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$-20.77noStage 1: -200% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$16.871.17xyesReference only (book value floor): BV/sh $16.87, ROE negative
Two-Stage Excess ReturnAsset$15.181.30xyesReference only (book value with convergence): BV/sh $16.87, ROE converges to ke
Discounted Future Market CapGrowth$6.003.29xyesRev $1.9B, growth -15% (input: historical growth; tapered), Terminal P/S: 0.8x / 1.1x / 1.3x (bear / base = today's held flat / bull, cap 6x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$41.110.48xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.51B × (1−21%) / WACC 4.9% → EPV (no growth)
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelativeno
FCF YieldEarnings$121.490.16xyesFCF $1421.5M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarningsno
ROIC-Justified P/BAssetno
P/Sales SectorRelative$21.310.93xyesRevenue $1.88B × sector P/S 1.2x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net debt$2.5b
Net debt / NOPAT (after-tax)5.84x
Net debt / operating income (pre-tax)4.61x
Interest coverage3.2x
Share count CAGR (dilution)6.4%
Burning cashno

Leverage and coverage are computed on normalized mid-cycle operating income (mid-cycle margin 29.0%); the trailing year was depressed.

Bullet Takeaways

Bull Case

Start with the balance sheet and cash, because that is where the bull case for an oil and gas name lives or dies. NOG carried about $2.5B of net debt into the most recent quarter, and management projects pro forma leverage near 1.4x to 1.6x after the Utica deal, with interest covered roughly three times over by operating profit. That is moderate leverage for an exploration and production company, and it is backed by cash that keeps coming regardless of the accounting. Despite the reported quarterly loss, cash from operations held at $323.6M, which funded the heavy investment program rather than draining the company. The headline number screamed distress; the cash account said business as usual.

The model itself is built for capital efficiency. As a non-operated owner, NOG buys fractional working interests in wells that other operators drill and run. It pays its share of the bill and takes its share of the barrels, without the field staff, the rigs, or the operating headcount that a traditional producer carries. That lets it spread capital across many wells and many basins, and it lets it grow by acquisition rather than by building an operating organization. The Utica purchase, a 40% interest closed for $464.5M in February 2026, is the strategy in action: write a check, add gas-weighted production and reserves, diversify out of the Bakken and Permian without standing up a new operating team.

The shareholder return is the part that makes the asset value tangible today. The quarterly dividend of $0.45 sets a yield above 8%, and the company has kept paying it through commodity swings. For an investor, the question is whether the cash flow that funds that dividend is durable, and the mid-cycle economics say yes: strip out the non-cash hedge marks and impairment, and the underlying operating margin runs near 29%. That is the business the price is actually buying, not the impaired trailing year. The price sits near the levels that asset value, earnings power, and peer multiples all support, which is a different and steadier footing than a pure growth bet.

Bear Case

The structural truth a holder has to face is that NOG does not control its own destiny. It owns minority, non-operated interests, which means other companies decide when wells get drilled, how fast, and at what cost. NOG funds its share and hopes the operators are disciplined. In a downturn, that lack of control cuts the wrong way: a non-operator cannot slow its own capital program independently, and it inherits whatever decisions the operating partners make. The growth lever is acquisition, and acquisition requires either cash the company is also paying out as dividends or new shares, and the share count has climbed about 6.4% a year. Dilution is the quiet cost of growing this way.

The commodity exposure is the real risk, and the latest quarter showed how violently it moves through the financials. The $268.3M ceiling-test impairment was not an accident of one bad quarter; it is structural to full-cost accounting. The filing spells out the mechanism: the carrying value of properties is capped at the discounted value of proved reserves priced off the trailing twelve-month unweighted average of the first-day-of-the-month price, so when oil prices fall, the cap falls and the company writes assets down. The 10-K warns plainly that we may be required to record further writedowns of our oil and natural gas properties in the future. A sustained slide in oil and gas prices does not just compress earnings here; it forces accounting losses and pressures the reserve base that backs the borrowing.

Leverage is the amplifier. Net debt near $2.5B sits at roughly 4.6 times mid-cycle operating income, and pro forma leverage is drifting up toward 1.6x after the Utica deal rather than down. The dividend yield above 8% is attractive precisely because the market is pricing real risk into it: an 8% yield on an E&P is the market saying the payout could be cut if prices break. The bear case is not that NOG fails. It is that an investor here is underwriting commodity prices staying firm enough to cover a rising debt load, a growing share count, and a dividend that competes with both for the same cash. The hedge book smooths the ride, but the $539.1M derivative loss in the quarter is a reminder that hedges cut both ways.

Valuation

The trailing financials are the wrong lens here, and it is worth saying why before any multiple. The most recent year ran a negative operating margin because of a non-cash ceiling-test impairment and large derivative marks, neither of which reflects the cash the wells actually produce. Value NOG on what it earns through a normal cycle, and the operating margin runs near 29%. That is the figure the price is built on, not the impaired headline.

On that mid-cycle basis, the methods line up in NOG's favor more than against it. Asset value, earnings power, and relative multiples all support today's price near $19, and only the growth-discounted cash-flow methods read it as expensive, which is exactly what you would expect for a mature, cash-generative producer that is not promising acceleration. The price sits at roughly 8 times blended earnings, a level that says the market is paying for the existing reserves and cash flow rather than for a growth story. This is a value-and-asset-supported name, and the spread among the methods says the downside is anchored by the assets, not floating on a multiple the market has to keep granting.

Solvency is where the caution belongs. Net debt of about $2.5B runs near 4.6 times mid-cycle operating income, interest coverage sits around three times, and the Utica acquisition nudges pro forma leverage up toward 1.6x rather than down. The dividend, at $0.45 a quarter and a yield above 8%, is covered by the operating cash flow the wells generate today, but it competes with debt service and the acquisition appetite for the same dollars. The bet the buyer underwrites is straightforward: commodity prices hold near a level that keeps mid-cycle economics intact, and the assets do the work the trailing accounting obscured.

Catalysts

The first quarter of 2026 was a study in the gap between accounting and cash. NOG reported a net loss of $522.8M, or negative $5.31 per diluted share, as a $539.1M loss on commodity derivatives and a $268.3M ceiling-test impairment overwhelmed oil and gas sales of $539.9M. Both the revenue and the EPS missed consensus, which had looked for about $516M of revenue and positive EPS, and the stock fell on the print. The signal under the noise was cash: operating cash flow held at $323.6M and production set a record, up 6% sequentially.

The defining strategic move is the Utica expansion. NOG closed a joint acquisition of Ohio Utica Shale interests on February 23, 2026, taking a 40% stake for $464.5M in cash alongside a partner holding the other 60%. The deal is gas-weighted and adds a third core area, but it pushes pro forma 2026 leverage from about 1.4x toward 1.6x and lifts debt-to-equity toward 1.43, the financing cost of growing by acquisition.

Analyst opinion splits on exactly that trade-off. Targets range from a Buy at $27 tied to the production and reserve growth from Utica, to a Hold at $16 citing the volatility and the complexity of the financials. The dividend, held at $0.45 a quarter for an 8%-plus yield, anchors the income case, and the question the next few prints answer is whether the acquired Utica volumes convert to the cash flow that covers a rising debt load and the payout at once.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

NOG Q1 2026 earnings release · NOG Q1 2026 results · NOG Q1 2026 earnings call · NOG 8-K, February 2026 · NOG acquisition disclosure, 2026 · analyst notes, 2026

View the full interactive NOG report on boothcheck